Matches in Nanopublications for { ?s ?p "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP697011.RAVNDJQFayoUtmZIYfJHF7m3651LrReJrK4usBZ1sazTg130_assertion description "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697011.RAVNDJQFayoUtmZIYfJHF7m3651LrReJrK4usBZ1sazTg130_provenance.
- NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_assertion description "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1013848.RAorRBbomw855aVoJSMDA_TraB0NVOGdsPT9gyDUupA6I130_provenance.
- NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_assertion description "[We show that immunoprecipitation (IP)-tandem mass spectrometry (LC-MS/MS) in H929 multiple myeloma (MM) cancer cells led to the discovery of a rare and unexpected BCR-ABL fusion, informing a therapeutic intervention using imatinib (Gleevec).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219241.RAzFZ2TXpX7xC-su7-ePdWGw3Y2xyMNZCpSRSYU-zWbQs130_provenance.